Hydrogel-exosome complexes: a novel strategy for cardiovascular regeneration

Area of Science:

• Biomedical Engineering
• Regenerative Medicine
• Cardiovascular Research

Background:

• Cardiovascular disease (CVD) is a major global health concern, driving the search for innovative treatments.
• Mesenchymal stem cell (MSC) therapy offers potential, with exosomes (Exos) being key bioactive components for cardiac repair.
• Current exosome applications for CVD face challenges including poor stability, inefficient delivery, and immune clearance.

Purpose of the Study:

• To review recent advancements in exosome-based therapies for cardiovascular disease (CVD).
• To explore the synergistic potential of combining exosomes with hydrogel biomaterials for enhanced CVD treatment.
• To provide insights for developing novel therapeutic strategies for CVD.

Main Methods:

• Literature review of current research on exosome therapy for CVD.
• Analysis of hydrogel properties and their application in enhancing exosome delivery and efficacy.
• Synthesis of findings on the combined use of exosomes and hydrogels for cardiovascular applications.

Main Results:

• Exosomes derived from MSCs contain noncoding RNAs and proteins crucial for cardiac function repair.
• Hydrogels demonstrate potential in improving exosome stability, controlled release, and targeted delivery.
• Synergistic application of exosomes and hydrogels presents a promising strategy to overcome current therapeutic limitations.

Conclusions:

• Exosomes represent a potent cell-free therapeutic approach for cardiovascular disease (CVD).
• Hydrogel biomaterials can significantly enhance the stability, delivery, and targeting of exosomes for CVD treatment.
• The combination of exosomes and hydrogels offers a promising avenue for advancing clinical translation and developing novel CVD therapies.